Preferred Label : Myasthenic syndrome, congenital, 6, presynaptic;
Symbol : CMS6;
CISMeF acronym : CMSEA; CMS1A2; CMS6; FIM; FIMG2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Myasthenic syndrome, presynaptic, congenital, associated with episodic apnea; Congenital myasthenic syndrome type ia2; Cms ia2; Myasthenia, familial infantile; CMSEA; FIM; FIMG2; CMS1A2; Myasthenia gravis, familial infantile, 2;
Description : Congenital myasthenic syndromes are genetic disorders of the neuromuscular junction
and can be classified by the site of the transmission defect: presynaptic, synaptic,
and postsynaptic. CMS-EA is an autosomal recessive form of presynaptic CMS. For a
discussion of genetic heterogeneity of CMS, see 608931. Neonatal myasthenia gravis
is a distinct disorder caused by passive transfer of maternal acetylcholine receptor
(AChR) autoantibodies to the fetus from a mother with myasthenia gravis (254200).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the choline acetyltransferase gene (CHAT, 118490.0001);
Prefixed ID : #254210;
Origin ID : 254210;
UMLS CUI : C0393929;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT